CTL ePBMC®

Using the ePBMC® search engine, you will be able to select human samples with defined HLA-type, antigen reactivity, demographics, vaccination status and more.

NEW! In addition to the IFN-γ characterization, data are now available, on the frequency of T cells that secrete IL-2, IL-4, IL-5, and IL-17 in response to Tetanus, EBV, and CMV (all HLA Class II-restricted antigens), and the CEF-Peptide Pool PLUS (an HLA Class I-restricted control antigen)

For immediate assistance please call +1-216-325-7232 during our business hours, 9:00AM-5:00PM (EDT).

Please click on the arrow on the left side of the sample row to see more information about the sample.

Lot number

HLA Class II DRB 3/4/5

Data pager

1 2 3 4 5 6 7 8 9 10

Page size:

PageSizeComboBox
	select

200 items in 10 pages

LP_487

399

>10x10^6

Hispanic

Female

A/Pos

A*02:05
A*24:02

B*15:01
B*49:01

C*01:02
C*07:01

DRB1*04:05
DRB1*04:07

DRB4*01:03
DRB4*01:03

not tested

DQB1*03:02
DQB1*03:02

DPA1*01:03
DPA1*01:03

DPB1*04:01G
DPB1*04:02G

CD16-Phe/Phe

IFN-g

LP_490

401

>10x10^6

Asian/Filipino

Male

0/Pos

A*24:07
A*34:01

B*15:13
B*35:05

C*04:01
C*04:01

DRB1*15:02
DRB1*15:02

DRB5*01:01
DRB5*01:01

not tested

DQB1*06:01
DQB1*06:01

DPA1*02:02
DPA1*02:02

DPB1*01:01G
DPB1*05:01G

CD16-Val/Phe

IFN-g

LP_492

402

>10x10^6

African/American

Male

0/Pos

A*30:01
A*30:01

B*42:01
B*42:01

C*17:01
C*17:01

DRB1*03:02
DRB1*11:02

DRB3*01:01
DRB3*02:02

not tested

DQB1*03:19
DQB1*04:02

DPA1*02:02
DPA1*02:12

DPB1*01:01G
DPB1*85:01G

CD16-Val/Val

IFN-g

LP_493

403

>10x10^6

Caucasian/African/American

Male

0/Pos

A*02:01
A*30:01

B*40:01
B*42:01

C*03:04
C*17:01

DRB1*13:02
DRB1*15:03

DRB3*03:01
DRB5*01:01

not tested

DQB1*06:02
DQB1*06:04

DPA1*01:03
DPA1*02:01

DPB1*13:01G
DPB1*16:01G

CD16-Val/Phe

IFN-g

LP_496

405

>10x10^6

Caucasian

Female

A/Pos

A*01:01
A*29:02

B*13:02
B*57:01

C*06:02
C*06:02

DRB1*04:02
DRB1*07:01

DRB4*01:03
DRB4*01:03

not tested

DQB1*02:02
DQB1*03:02

DPA1*01:03
DPA1*02:01

DPB1*02:01G
DPB1*14:01G

CD16-Phe/Phe

IFN-g

LP_497

406

>10x10^6

Hispanic

Male

0/Neg

A*02:01
A*26:01

B*14:01
B*35:01

C*04:01
C*08:02

DRB1*07:01
DRB1*16:02

DRB4*01:01
DRB5*02:02

not tested

DQB1*02:02
DQB1*03:01

DPA1*01:03
DPA1*01:03

DPB1*02:01G
DPB1*04:02G

CD16-Val/Phe

IFN-g

LP_498

407

>10x10^6

African/American

Male

0/Pos

A*02:02
A*03:01

B*35:01
B*44:02

C*04:01
C*05:01

DRB1*15:01
DRB1*15:03

DRB5*01:01
DRB5*01:01

not tested

DQB1*06:02
DQB1*06:02

DPA1*02:06
DPA1*03:01

not tested

CD16-Phe/Phe

IFN-g

LP_499

408

>10x10^6

Caucasian

Male

TBD

A*01:01
A*02:01

B*44:02
B*58:01

C*05:01
C*07:18

DRB1*04:02
DRB1*07:01

DRB4*01:03
DRB4*01:03

DQA1*02:01
DQA1*03:01

DQB1*02:02
DQB1*03:02

DPA1*01:03
DPA1*02:01

DPB1*04:01
DPB1*05:01

CD16-Val/Phe

IFN-g

LP_500

409

>10x10^6

Caucasian

Male

0/Pos

A*01:01
A*02:01

B*44:02
B*57:01

C*05:01
C*06:02

DRB1*04:01
DRB1*13:05

DRB3*02:02
DRB4*01:03

not tested

DQB1*03:01
DQB1*03:01

DPA1*01:03
DPA1*01:03

DPB1*04:01G
DPB1*04:01G

CD16-Val/Phe

IFN-g

LP_501

410

>10x10^6

Hispanic

Male

A/Pos

A*02:01
A*11:01

B*18:01
B*55:01

C*03:03
C*07:01

DRB1*12:01
DRB1*14:54

DRB3*02:02
DRB3*02:02

not tested

DQB1*03:01
DQB1*05:03

DPA1*01:03
DPA1*01:03

DPB1*02:01G
DPB1*04:01G

CD16-Val/Phe

IFN-g

LP_504

413

>10x10^6

Hispanic

Female

A/Neg

A*02:02
A*32:01

B*44:03
B*51:01

C*14:02
C*16:01

DRB1*07:01
DRB1*14:54

DRB3*02:02
DRB4*01:01

not tested

DQB1*02:02
DQB1*05:03

DPA1*01:03
DPA1*02:01

DPB1*04:01G
DPB1*10:01G

CD16-Phe/Phe

IFN-g

LP_505

414

>10x10^6

Hispanic

Male

B/Neg

A*26:01
A*33:03

B*18:01
B*51:01

C*07:01
C*12:03

DRB1*11:01
DRB1*11:01

DRB3*02:02
DRB3*02:02

not tested

DQB1*03:01
DQB1*03:01

DPA1*01:03
DPA1*01:03

DPB1*04:01G
DPB1*04:02G

CD16-Val/Phe

IFN-g

LP_506

415

>10x10^6

Hispanic

Female

A/Pos

A*11:01
A*29:02

B*08:01
B*51:01

C*07:01
C*15:02

DRB1*04:04
DRB1*16:02

DRB4*01:03
DRB5*02:02

DQA1*03:01
DQA1*05:05

DQB1*03:01
DQB1*03:02

DPA1*01:03
DPA1*01:03

DPB1*04:02
DPB1*04:02

CD16-Phe/Phe

IFN-g

LP_507

416

>10x10^6

Hispanic

Male

0/Pos

A*02:01
A*24:03

B*35:01
B*35:12

C*04:01
C*04:01

DRB1*08:02
DRB1*13:01

DRB3*02:02

DQA1*01:03
DQA1*04:01

DQB1*04:02
DQB1*06:03

DPA1*01:03
DPA1*02:07

DPB1*04:02
DPB1*19:01

CD16-Val/Phe

IFN-g

LP_509

418

>10x10^6

African/American

Male

0/Pos

A*02:05
A*23:01

B*53:01
B*53:01

C*04:01
C*06:02

DRB1*01:02
DRB1*14:54

DRB3*02:02

DQA1*01:01
DQA1*01:05

DQB1*05:01
DQB1*06:02

DPA1*02:01
DPA1*03:01

DPB1*105:01
DPB1*11:01

CD16-Val/Phe

IFN-g

LP_510

419

>10x10^6

African/American

Male

A/Pos

A*23:01
A*33:01

B*07:06
B*42:01

C*07:02
C*17:01

DRB1*01:01
DRB1*03:02

DRB3*01:01

DQA1*01:01
DQA1*04:01

DQB1*04:02
DQB1*05:01

DPA1*02:01
DPA1*02:12

DPB1*01:01
DPB1*85:01

CD16-Phe/Phe

IFN-g

LP_511

420

>10x10^6

Hispanic

Male

0/Pos

A*23:01
A*30:01

B*35:02
B*53:01

C*04:01
C*08:02

DRB1*11:01
DRB1*13:01

DRB3*02:02
DRB3*02:02

DQA1*01:02
DQA1*01:03

DQB1*06:02
DQB1*06:03

DPA1*01:03
DPA1*01:03

DPB1*02:01
DPB1*04:01

CD16-Val/Val

IFN-g

LP_512

421

>10x10^6

Hispanic

Male

B/Pos

A*03:01
A*66:01

B*18:01
B*51:01

C*05:01
C*16:02

DRB1*03:01
DRB1*11:04

DRB3*02:02
DRB3*02:02

DQA1*05:01
DQA1*05:05

DQB1*02:01
DQB1*03:01

DPA1*01:03
DPA1*02:01

DPB1*104:01
DPB1*11:01

CD16-Val/Phe

IFN-g

LP_518

427

>10x10^6

African/American

Male

A/Pos

A*24:02
A*33:03

B*14:02
B*18:01

C*07:01
C*08:02

DRB1*11:01
DRB1*15:03

DRB3*02:02
DRB5*01:01

DQA1*01:02
DQA1*05:05

DQB1*03:01
DQB1*06:02

DPA1*01:03
DPA1*01:03

DPB1*02:01
DPB1*04:01

CD16-Phe/Phe

not tested

LP_520

251

>10x10^6

Hispanic

Male

0/Pos

A*02:01
A*24:02

B*39:05
B*51:01

C*02:02
C*07:02

DRB1*04:03
DRB1*04:07

DRB4*01:03
DRB4*01:03

not tested

DQB1*03:02
DQB1*03:04

DPA1*01:03
DPA1*01:03

DPB1*04:01G
DPB1*04:02G

CD16-Phe/Phe

IFN-g